Fasitibant free base structure
|
Common Name | Fasitibant free base | ||
---|---|---|---|---|
CAS Number | 869939-83-3 | Molecular Weight | 764.78 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C36H49Cl2N6O6S+ | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Fasitibant free baseFasitibant (free base) is a potent, selective, high affinity, and long-lasting nonpeptide bradykinin B2 (BK2) receptor antagonist. Fasitibant (free base) has proinflammatory effects and can be used for the research of osteoarthritis and rheumatoid arthritis[1]. |
Name | Fasitibant free base |
---|
Description | Fasitibant (free base) is a potent, selective, high affinity, and long-lasting nonpeptide bradykinin B2 (BK2) receptor antagonist. Fasitibant (free base) has proinflammatory effects and can be used for the research of osteoarthritis and rheumatoid arthritis[1]. |
---|---|
Related Catalog | |
Target |
Bradykinin B2 Receptor (B2R) |
In Vitro | Fasitibant (free base) (1 µM;30 min) 减少了滑膜细胞中 BK 诱导的 PGE2 形成和 COX-2 基因表达[1]。 |
In Vivo | Fasitibant (free base) (100 µg;膝盖注射;单剂量) 显著降低了大鼠中卡拉胶 (Carrageenan,HY-125474) 诱导的 IL-1b、IL-6、GRO/CINC-1 滑膜细胞因子的释放,PGE 代谢产物的形成,髓过氧化物酶 (MPO) 的活性,当与地塞米松 (Dexamethasone,HY-14648) 联用时效果更显著[2]。 |
References |
Molecular Formula | C36H49Cl2N6O6S+ |
---|---|
Molecular Weight | 764.78 |